Lyon, F-69372
France
University of Claude Bernard Lyon 1 - CIRI
SARS-CoV-2, breakthrough infection, hybrid immunity, immune trajectory, IgG4 class-switching, ADCC function
Covid-19vaccinationantibodiesneutralizing antibodiesvirus-specific T cellsvaccine effectiveness